Steve Weinrauch Sells 6,674 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) EVP Steve Weinrauch sold 6,674 shares of the business’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $22.00, for a total value of $146,828.00. Following the transaction, the executive vice president owned 78,062 shares of the company’s stock, valued at approximately $1,717,364. The trade was a 7.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Trupanion Trading Up 0.5%

TRUP stock traded up $0.12 during midday trading on Tuesday, reaching $22.17. The company’s stock had a trading volume of 278,529 shares, compared to its average volume of 372,582. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $57.88. The firm has a market capitalization of $967.06 million, a price-to-earnings ratio of 37.58 and a beta of 1.45. The stock has a fifty day simple moving average of $24.39 and a two-hundred day simple moving average of $29.50. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.73 and a current ratio of 1.73.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The firm had revenue of $384.05 million for the quarter, compared to analysts’ expectations of $379.77 million. During the same period in the prior year, the business posted ($0.03) earnings per share. The business’s revenue for the quarter was up 12.3% on a year-over-year basis. On average, equities research analysts predict that Trupanion, Inc. will post 0.53 EPS for the current year.

Hedge Funds Weigh In On Trupanion

Institutional investors have recently bought and sold shares of the business. Federated Hermes Inc. bought a new stake in Trupanion during the 3rd quarter valued at $33,000. Parallel Advisors LLC lifted its position in shares of Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after buying an additional 1,722 shares during the last quarter. Kemnay Advisory Services Inc. purchased a new stake in shares of Trupanion during the fourth quarter valued at about $64,000. Kelleher Financial Advisors bought a new stake in shares of Trupanion in the 3rd quarter valued at about $74,000. Finally, PNC Financial Services Group Inc. grew its position in shares of Trupanion by 21.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock worth $116,000 after buying an additional 478 shares during the last quarter.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Stifel Nicolaus lowered their price target on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a report on Tuesday, March 31st. Bank of America decreased their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Zacks Research cut Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Cantor Fitzgerald dropped their price target on Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $42.25.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.